US1331311027 - REIT

Taking everything into account, **CPT** scores **4** out of 10 in our fundamental rating. **CPT** was compared to 20 industry peers in the **Residential REITs** industry. **CPT** scores excellent on profitability, but there are concerns on its financial health. **CPT** has a valuation in line with the averages, but on the other hand it scores bad on growth.

In the past year **CPT** was profitable.

Each year in the past 5 years **CPT** had a positive operating cash flow.

With an excellent **Return On Assets** value of **5.34%**, **CPT** belongs to the best of the industry, outperforming **95.00%** of the companies in the same industry.

Looking at the **Return On Equity**, with a value of **9.88%**, **CPT** belongs to the top of the industry, outperforming **85.00%** of the companies in the same industry.

The **Return On Invested Capital** of **CPT** (**3.73%**) is better than **90.00%** of its industry peers.

The **Average Return On Invested Capital** over the past 3 years for **CPT** is in line with the industry average of **2.59%**.

The 3 year average ROIC (**2.63%**) for **CPT** is below the current ROIC(**3.73%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.34% | ||

ROE | 9.88% | ||

ROIC | 3.73% |

ROA(3y)5.03%

ROA(5y)4.01%

ROE(3y)9.47%

ROE(5y)7.61%

ROIC(3y)2.63%

ROIC(5y)2.68%

With a **Operating Margin** value of **20.69%**, **CPT** perfoms like the industry average, outperforming **55.00%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **CPT** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 20.69% | ||

PM (TTM) | 25.26% | ||

GM | 61.94% |

OM growth 3Y1.29%

OM growth 5Y-3.25%

PM growth 3Y30.13%

PM growth 5Y9.97%

GM growth 3Y1.45%

GM growth 5Y0.41%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **CPT** is destroying value.

Compared to 1 year ago, **CPT** has more shares outstanding

The number of shares outstanding for **CPT** has been increased compared to 5 years ago.

An Altman-Z score of **1.88** indicates that **CPT** is not a great score, but indicates only limited risk for bankruptcy at the moment.

Looking at the **Altman-Z score**, with a value of **1.88**, **CPT** is in the better half of the industry, outperforming **80.00%** of the companies in the same industry.

Looking at the **Debt to FCF ratio**, with a value of **9.71**, **CPT** belongs to the top of the industry, outperforming **95.00%** of the companies in the same industry.

The **Debt to Equity ratio** of **CPT** (**0.66**) is better than **80.00%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.66 | ||

Debt/FCF | 9.71 | ||

Altman-Z | 1.88 |

ROIC/WACC0.5

WACC7.41%

The **Current ratio** of **CPT** (**0.15**) is worse than **80.00%** of its industry peers.

With a **Quick ratio** value of **0.15**, **CPT** is not doing good in the industry: **70.00%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.15 | ||

Quick Ratio | 0.15 |

Measured over the past years, **CPT** shows a quite strong growth in **Earnings Per Share**. The EPS has been growing by **18.09%** on average per year.

The **Revenue** has been growing by **10.07%** on average over the past years. This is quite good.

EPS 1Y (TTM)-27.05%

EPS 3Y44.23%

EPS 5Y18.09%

EPS Q2Q%97.44%

Revenue 1Y (TTM)6.9%

Revenue growth 3Y13.89%

Revenue growth 5Y10.07%

Sales Q2Q%1.32%

Based on estimates for the next years, **CPT** will show a very negative growth in **Earnings Per Share**. The EPS will decrease by **-16.64%** on average per year.

EPS Next Y-47.53%

EPS Next 2Y-33.07%

EPS Next 3Y-16.64%

EPS Next 5YN/A

Revenue Next Year0.19%

Revenue Next 2Y0.96%

Revenue Next 3Y2.42%

Revenue Next 5Y4.26%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

A **Price/Earnings** ratio of **27.55** indicates a quite expensive valuation of **CPT**.

100.00% of the companies in the same industry are more expensive than **CPT**, based on the **Price/Earnings** ratio.

Compared to an average S&P500 **Price/Earnings** ratio of **29.53**, **CPT** is valued at the same level.

The **Price/Forward Earnings** ratio is **67.78**, which means the current valuation is very expensive for **CPT**.

The rest of the industry has a similar **Price/Forward Earnings** ratio as **CPT**.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 27.55 | ||

Fwd PE | 67.78 |

Based on the **Enterprise Value to EBITDA** ratio, **CPT** is valued cheaply inside the industry as 95.00% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 32.88 | ||

EV/EBITDA | 15.7 |

A cheap valuation may be justified as **CPT**'s earnings are expected to decrease with **-16.64%** in the coming years.

PEG (NY)N/A

PEG (5Y)1.52

EPS Next 2Y-33.07%

EPS Next 3Y-16.64%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.77% |

The dividend of **CPT** has a limited annual growth rate of **5.90%**.

Dividend Growth(5Y)5.9%

Div Incr Years6

Div Non Decr Years13

DP90.81%

EPS Next 2Y-33.07%

EPS Next 3Y-16.64%

**CAMDEN PROPERTY TRUST**

NYSE:CPT (7/17/2024, 3:11:55 PM)

After market: 112.96 0 (0%)**112.96**

**+1.73 (+1.56%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryResidential REITs

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap12.03B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.77% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 27.55 | ||

Fwd PE | 67.78 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)1.52

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.34% | ||

ROE | 9.88% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 20.69% | ||

PM (TTM) | 25.26% | ||

GM | 61.94% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.21

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.66 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.15 | ||

Quick Ratio | 0.15 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-27.05%

EPS 3Y44.23%

EPS 5Y

EPS Q2Q%

EPS Next Y-47.53%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)6.9%

Revenue growth 3Y13.89%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y